Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MNOV | -20.66% | $97.60M | +33.11% | 0.00% |
GERN | -19.00% | $2.07B | +64.42% | 0.00% |
SYPR | -17.97% | $48.81M | -0.47% | 0.00% |
APRE | -16.74% | $21.41M | -33.89% | 0.00% |
STZ | -16.15% | $39.81B | -13.93% | 2.07% |
IX | -14.46% | $23.70B | +7.94% | 3.86% |
TCTM | -13.96% | $6.04M | -47.64% | 0.00% |
FF | -11.46% | $226.26M | +28.39% | 4.70% |
NHTC | -11.22% | $53.42M | -24.18% | 16.85% |
OXBR | -11.13% | $23.95M | +254.05% | 0.00% |
PSQH | -11.01% | $172.99M | -20.90% | 0.00% |
CAMT | -10.71% | $4.12B | +30.32% | 0.00% |
BPT | -9.97% | $11.83M | -80.05% | 0.00% |
SPTN | -9.56% | $609.28M | -20.73% | 4.84% |
CBOE | -9.34% | $20.20B | +9.90% | 1.22% |
MPWR | -9.28% | $30.29B | +5.39% | 0.86% |
TNDM | -9.23% | $2.46B | +38.54% | 0.00% |
TG | -9.05% | $259.08M | +45.28% | 0.00% |
FUBO | -8.40% | $1.79B | +81.97% | 0.00% |
NOMD | -8.38% | $2.61B | -10.76% | 2.89% |
Yahoo
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
Finnhub
DEER PARK - Eton Pharmaceuticals, Inc , an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it has acquired Galzin...
Yahoo
Adds an additional commercial and strategic rare disease product to Eton’s portfolioGalzin is FDA-approved for the treatment of the ultra-rare metabolic condition of Wilson Disease DEER PARK, Ill., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it has acquired Galzin® (zinc acetate). “This acquisition furthers our
Finnhub
Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin® ● ...
Finnhub
DEER PARK - Eton Pharmaceuticals, Inc , an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it has completed its...
Yahoo
Acquisition bolsters Eton’s commercial pediatric endocrinology portfolioProduct is now available through AnovoRx, a specialty pharmacy dedicated to serving patients with rare and chronic conditions DEER PARK, Ill., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it has completed its previously announced asset purch
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SNY | <0.01% | $122.86B | -6.07% | 4.16% |
BACK | 0.01% | $2.62M | -45.83% | 0.00% |
AEM | -0.01% | $41.81B | +60.12% | 1.89% |
SAN | -0.02% | $69.22B | +11.75% | 4.55% |
XOM | 0.04% | $469.97B | +8.35% | 3.61% |
RAPT | 0.06% | $50.69M | -94.04% | 0.00% |
HQY | 0.07% | $8.64B | +39.30% | 0.00% |
PCG | 0.08% | $42.23B | +6.00% | 0.31% |
PGNY | -0.08% | $1.55B | -51.99% | 0.00% |
GSM | -0.08% | $736.51M | -36.36% | 1.35% |
NOK | 0.08% | $25.37B | +33.52% | 3.11% |
UNH | 0.08% | $482.71B | -2.44% | 1.54% |
CYD | -0.09% | $431.87M | +26.44% | 3.67% |
LTM | 0.10% | $8.18B | -100.00% | <0.01% |
FNKO | 0.10% | $764.48M | +100.83% | 0.00% |
IMAB | -0.11% | $84.73M | -50.67% | 0.00% |
AOMR | -0.12% | $230.18M | -7.73% | 13.42% |
STG | 0.12% | $28.35M | -39.33% | 0.00% |
FUN | -0.13% | $4.71B | +23.00% | 1.33% |
ELF | -0.14% | $7.19B | -18.01% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SSYS | 31.77% | $633.96M | -34.59% | 0.00% |
HNST | 30.43% | $639.08M | +115.31% | 0.00% |
SOLV | 28.30% | $11.91B | -13.80% | 0.00% |
TGTX | 27.87% | $4.48B | +61.90% | 0.00% |
DVAX | 27.32% | $1.66B | -8.62% | 0.00% |
ABCL | 26.00% | $894.96M | -46.18% | 0.00% |
GFF | 25.97% | $3.45B | +22.20% | 0.90% |
GPMT | 25.73% | $136.88M | -53.16% | 11.30% |
FDX | 25.48% | $66.21B | +9.60% | 1.98% |
RKLB | 24.97% | $13.68B | +412.36% | 0.00% |
PULM | 24.94% | $21.88M | +193.63% | 0.00% |
PD | 24.70% | $1.60B | -33.17% | 0.00% |
IBEX | 24.58% | $360.44M | +24.49% | 0.00% |
BNTX | 24.50% | $29.28B | +15.24% | 0.00% |
BL | 24.38% | $3.57B | -1.86% | 0.00% |
TDOC | 24.36% | $1.68B | -55.14% | 0.00% |
MCB | 24.36% | $636.92M | +11.81% | 0.00% |
PRTA | 24.34% | $761.93M | -60.52% | 0.00% |
EVGO | 24.27% | $444.77M | +40.96% | 0.00% |
BW | 24.21% | $153.74M | +30.40% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
DVYE | 0.02% | $637.74M | 0.49% |
GDXJ | 0.03% | $4.60B | 0.52% |
CQQQ | 0.08% | $643.76M | 0.65% |
XBIL | -0.10% | $641.82M | 0.15% |
AIA | 0.10% | $719.96M | 0.5% |
URNJ | 0.12% | $268.81M | 0.8% |
CSHI | -0.14% | $508.09M | 0.38% |
BILZ | 0.15% | $624.51M | 0.14% |
GDX | -0.23% | $13.08B | 0.51% |
AAXJ | -0.28% | $2.47B | 0.72% |
IBD | -0.29% | $334.48M | 0.44% |
GSG | 0.36% | $1.02B | 0.75% |
EWJV | -0.40% | $253.72M | 0.15% |
COMT | -0.42% | $694.40M | 0.48% |
GCC | 0.42% | $131.62M | 0.55% |
DBMF | 0.55% | $1.27B | 0.85% |
EPU | -0.61% | $72.53M | 0.59% |
EWH | 0.61% | $611.40M | 0.5% |
PICK | -0.62% | $777.71M | 0.39% |
EDIV | -0.67% | $539.83M | 0.65% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TBIL | -12.73% | $4.78B | 0.15% |
AGZD | -12.40% | $142.56M | 0.23% |
CPER | -11.80% | $148.40M | 0.97% |
EQLS | -10.86% | $8.97M | 1% |
VIXY | -10.31% | $195.31M | 0.85% |
CTA | -10.13% | $483.80M | 0.76% |
KMLM | -8.35% | $334.70M | 0.9% |
TPMN | -7.44% | $41.62M | 0.65% |
MSOS | -6.77% | $505.06M | 0.83% |
YOLO | -5.90% | $32.55M | 1.03% |
AMDY | -5.57% | $167.46M | 0.99% |
CNBS | -5.33% | $12.78M | 0.77% |
BIL | -5.11% | $36.56B | 0.1356% |
TAIL | -4.99% | $65.56M | 0.59% |
DBB | -4.89% | $110.21M | 0.77% |
XHLF | -4.71% | $939.75M | 0.03% |
MCHI | -4.40% | $5.27B | 0.6% |
FXI | -4.38% | $7.00B | 0.74% |
COPX | -4.37% | $2.66B | 0.65% |
GXC | -4.32% | $390.72M | 0.59% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FBT | 28.62% | $1.13B | 0.56% |
IHE | 27.07% | $602.79M | 0.39% |
PBE | 26.70% | $251.02M | 0.58% |
XPH | 25.45% | $158.74M | 0.35% |
XBI | 24.62% | $6.39B | 0.35% |
ARKG | 24.56% | $1.16B | 0.75% |
WCLD | 24.18% | $465.15M | 0.45% |
IBB | 24.02% | $6.59B | 0.45% |
CLOU | 23.69% | $350.27M | 0.68% |
ARKX | 23.11% | $302.97M | 0.75% |
XAR | 22.87% | $2.67B | 0.35% |
GNOM | 22.78% | $71.12M | 0.5% |
BBH | 22.70% | $404.15M | 0.35% |
XSW | 22.37% | $508.32M | 0.35% |
VXF | 22.09% | $21.57B | 0.06% |
FXH | 21.95% | $1.07B | 0.62% |
ICVT | 21.76% | $2.60B | 0.2% |
BUG | 21.73% | $799.87M | 0.5% |
KBWD | 21.73% | $406.96M | 2.02% |
VWOB | 21.71% | $4.87B | 0.2% |
Current Value
$12.251 Year Return
Current Value
$12.251 Year Return